High frequency of non-classical congenital adrenal hyperplasia form among children with persistently elevated levels of 17-hydroxyprogesterone after newborn screening

Imagem de Miniatura
Arquivos
art_CASTRO_High_frequency_of_nonclassical_congenital_adrenal_hyperplasia_form_2019.PDF (117.87 KB)
Citações na Scopus
2
Tipo de produção
article
Data de publicação
2019
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
WALTER DE GRUYTER GMBH
Autores
CASTRO, Patricia S.
RASSI, Tatiana O.
ARAUJO, Raquel F.
PEZZUTI, Isabela L.
SILVA, Ivani N.
Citação
JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, v.32, n.5, p.499-504, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: Early diagnosis after newborn screening (NBS) for congenital adrenal hyperplasia (CAH) allows proper treatment, reducing mortality rates and preventing development of hyperandrogenic manifestations and incorrect sex assignment at birth. Despite the high NBS sensitivity to detect CAH classical forms, one of the main issues is identifying asymptomatic children who remained with increased 17-hydroxyprogesterone (17-OHP) levels. In this study, we aimed to contribute to understanding the diagnosis of these children. Methods: Children with increased serum 17-OHP levels, and without disease-related clinical features during follow-up, underwent the entire CYP21A2 gene sequencing and multiplex ligation-dependent probe amplification (MLPA) analysis (SALSA MLPA P050B CAH). Patients' genotypes were subsequently sorted as compatible with CAH disease, and children were evaluated to determine the clinical status. Results: During the study period, 106,476 newborns underwent CAH NBS. During follow-up, 328 children (0.3%) were identified as having false-positive tests and 295 were discharged after presenting with 17-OHP levels within reference values. Thirty-three remained asymptomatic and with increased serum 17-OHP levels after a mean follow-up of 3.4 years, and were subjected to molecular analysis. Seventeen out of the 33 children carried mutations: seven in the heterozygous state, nine carried non-classical genotypes and the remaining child carried a classical genotype. Conclusions: We found a high frequency of non-classical CAH (NCCAH) diagnosis among children with persistent elevation of 17-OHP levels. Our findings support molecular study as decisive for elucidating diagnosis in these asymptomatic children. Molecular analysis as a confirmatory test is relevant to guide their follow-up, allows genetic counseling and avoids over treating NCCAH form.
Palavras-chave
congenital adrenal hyperplasia, 21-hydroxylase deficiency, newborn screening
URI
https://observatorio.fm.usp.br/handle/OPI/32410
Referências
  1. Anandi VS, 2017, J PEDIATR ENDOCR MET, V30, P677, DOI 10.1515/jpem-2016-0459
  2. Bachega Tânia A.S.S., 2004, Arq Bras Endocrinol Metab, V48, P697, DOI 10.1590/S0004-27302004000500016
  3. Campos VC, 2009, ARQ BRAS ENDOCRINOL, V53, P40, DOI 10.1590/S0004-27302009000100007
  4. Cavarzere P, 2009, EUR J ENDOCRINOL, V161, P285, DOI 10.1530/EJE-09-0145
  5. Corrêa Fernanda de Azevedo, 2003, Arq Bras Endocrinol Metab, V47, P622, DOI 10.1590/S0004-27302003000500017
  6. de Silva KSH, 2014, J PEDIATR ENDOCR MET, V27, P475, DOI 10.1515/jpem-2013-0267
  7. El-Maouche D, 2017, LANCET, V390, P2194, DOI 10.1016/S0140-6736(17)31431-9
  8. Gidlof S, 2014, JAMA PEDIATR, V168, P567, DOI 10.1001/jamapediatrics.2013.5321
  9. Gidlof S, 2013, LANCET DIABETES ENDO, V1, P35, DOI 10.1016/S2213-8587(13)70007-X
  10. Hayashi GY, 2017, CLIN ENDOCRINOL, V86, P480, DOI 10.1111/cen.13292
  11. Kopacek Cristiane, 2019, J Pediatr (Rio J), V95, P282, DOI 10.1016/j.jped.2018.03.003
  12. Kopacek C, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-016-0772-x
  13. Kosel S, 2005, CLIN CHEM, V51, P298, DOI 10.1373/clinchem.2004.042416
  14. Magnisali P, 2011, J CHROMATOGR B, V879, P1565, DOI 10.1016/j.jchromb.2011.03.048
  15. Malikova J, 2012, CLIN ENDOCRINOL, V77, P187, DOI 10.1111/j.1365-2265.2012.04358.x
  16. Matern D, 2007, J INHERIT METAB DIS, V30, P585, DOI 10.1007/s10545-007-0691-y
  17. Mello Maricilda Pallandi de, 2002, Arq Bras Endocrinol Metab, V46, P457, DOI 10.1590/S0004-27302002000400017
  18. New MI, 2006, J CLIN ENDOCR METAB, V91, P4205, DOI 10.1210/jc.2006-1645
  19. Nimkarn S, 1993, GENEREVIEWS
  20. Nordenstrom A, 1999, J CLIN ENDOCR METAB, V84, P1505, DOI 10.1210/jc.84.5.1505
  21. Pezzuti IL, 2014, J PEDIAT-BRAZIL, V90, P300, DOI 10.1016/j.jped.2013.09.007
  22. Silveira EL, 2009, CLIN GENET, V76, P503, DOI 10.1111/j.1399-0004.2009.01274.x
  23. Soardi FC, 2008, ARQ BRAS ENDOCRINOL, V52, P1388, DOI 10.1590/S0004-27302008000800030
  24. Speiser PW, 2009, REV ENDOCR METAB DIS, V10, P77, DOI 10.1007/s11154-008-9097-x
  25. Tajima T, 2016, CLIN PEDIATR ENDOCRI, V25, P1, DOI 10.1297/cpe.25.1
  26. Therrell BL, 2015, SEMIN PERINATOL, V39, P171, DOI 10.1053/j.semperi.2015.03.002
  27. VANDERKAMP HJ, 2004, EUR J ENDOCRINOL S3, V151
  28. WILSON RC, 1995, J CLIN ENDOCR METAB, V80, P1635, DOI 10.1210/jc.80.5.1635
  29. 2012, ARCH PEDIAT ADOLESC, V166, P113
  30. 2018, MOL DIAGN THER, V22, P261, DOI 10.1007/S40291-018-0319-Y

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/42